Replies to post #505523 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Rescue medication is for when a drug fails (PFS in this case). But it is giving the patient extra dosing that increases the likelihood of survival which bias the OS data. That's what confounding is -- when the trial design biases the trial in favor of the treatment arm.